Lexicon Pharmaceuticals

LXRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$970.004 M

$2.18 +6.86%

Close of 22 Sept 2026

Revenue

$49.8M

#2733 by revenue

Earnings

-$50.3M

Loss-making

Shares outstanding

444,955,934

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#159Arbutus BiopharmaABUS$991.2M
#160Pacira BioSciencesPCRX$984.6M
#161Lexicon PharmaceuticalsLXRX$970.0M
#162Immix BiopharmaIMMX$917.8M
#163Rigel PharmaceuticalsRIGL$912.0M

What if Lexicon Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.2T

$67,948.23

Per share 31,169× higher

Bitcoin $1.74T

$3,914.22

Per share 1,796× higher

Nvidia $5.52T

$12,396.21

Per share 5,686× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Lexicon Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.